From sharing experiences to shaping understanding: why the Patient voice and meaningful healthcare communication matter more than ever.
In 2020, Talking Medicines explored how women were turning to social media for information, reassurance, and support as they navigated menopause.
At the time, menopause was beginning to gain greater visibility online, but conversations around symptoms, treatment options, and everyday experiences remained surrounded by stigma and misunderstanding.
Six years later, in 2026, the landscape looks different. Menopause has become a more prominent topic across social media, healthcare, workplaces, and mainstream media. Women are sharing experiences, connecting with others, and helping to build communities where menopause can be discussed more openly.
Following World Menopause Day on October 18, it’s an opportunity to reflect on how these conversations have evolved. This year’s theme, Chronic Pain at Midlife, also highlights the importance of recognizing the many different ways menopause can affect women’s health and well-being.
But six years on, how has the online conversation evolved, and what can we learn from the experiences being shared?
Menopause Conversations Are Reaching New Audiences
When we first explored menopause discussions online, women were increasingly seeking support through digital communities, often sharing experiences they felt less comfortable discussing elsewhere.
Today, research reinforces just how important these platforms have become.A 2025 study published in Post Reproductive Health, involving 1,596 respondents, found that 53% had turned to social media for menopause information, with Instagram emerging as the most popular platform. The same research found that 92.7% had actively sought menopause information, yet only 21.9% felt well-informed.
While these findings don’t provide a direct comparison with 2020, they highlight the important role digital communities play and the continued need for accessible, relevant information. Across social media, women are discussing everything from perimenopause symptoms and hormone replacement therapy (HRT) to sleep disruption, brain fog, and the everyday impact of menopause.
These conversations provide reassurance, shared understanding, and opportunities to learn from others. They also offer valuable perspectives on how menopause is experienced in real life, in women’s own words.
Greater Visibility, but Are Women’s Needs Being Understood?
While increased awareness is encouraging, greater visibility doesn’t necessarily mean every woman feels informed, understood, or supported. The 2025 menopause study also found that 59.1% of respondents felt the information and support they accessed wasn’t tailored to their specific needs.
This highlights the difference between making information available and ensuring it is relevant to those seeking it. The importance of feeling understood extends beyond menopause. A recent Fierce Pharma article exploring women’s trust in healthcare highlighted research involving 1,000 US women ages 18–44, finding that 73% had felt dismissed or not taken seriously by Healthcare Providers because of their gender.
Although this research examined women’s healthcare more broadly, it reinforces the importance of understanding individual experiences and building trust through meaningful communication.For Pharma and Agencies, real-life Patient conversations can provide important context around the questions, concerns, and information needs that traditional engagement metrics may not fully capture.
Why Message Resonance Matters
As menopause conversations become more visible, how healthcare information is communicated matters just as much as the information itself. A 2026 study published in JMIR Formative Research explored how different social media narratives influenced women’s responses to menopause-related content. The study involved 737 perimenopausal and postmenopausal women in the UK and found that distress-focused messaging increased feelings of worry, confusion, and anxiety compared with normalization-focused messaging.
Interestingly, these emotional differences did not translate into significant differences in participants’ intentions to engage with the content through likes, shares, or comments. A message can attract attention without necessarily creating the understanding, reassurance, or connection its audience needs. For Pharma and Agency partners, this highlights the importance of looking beyond reach and engagement to better understand how healthcare messages align with the real-life experiences and priorities of Patients.
It also reinforces why understanding the perspectives of both Patients and Healthcare Professionals (HCPs) matters. Patients bring their lived experiences, questions, and treatment expectations, while HCPs bring clinical expertise and treatment considerations.
Understanding both perspectives can help inform communications that are relevant, respectful, and grounded in the needs of their intended audiences.
From Conversations to Intelligence: The Role of DrugVoice
Behind every online conversation is a person sharing an experience, asking a question, or seeking reassurance.When these conversations are curated and analyzed ethically, they can provide valuable insights into the lived Patient experience and help the healthcare industry better understand unmet needs. This is where DrugVoice comes in. Talking Medicines DrugVoice intelligence platform connects signals from real-life Patient and HCP conversations, transforming complex healthcare data into actionable intelligence for Pharma and Agency partners.
By understanding what matters to different audiences, how healthcare topics are being discussed, and where perspectives align or differ, DrugVoice helps inform more relevant and meaningful healthcare communications.Through its proprietary Message Resonance Score™, DrugVoice enables teams to understand how messages resonate with Patient and HCP audiences, identify gaps between messaging and real-life conversations, and explore why certain messages connect more strongly than others.
This intelligence can help Pharma and Agency partners refine communications and make more informed messaging decisions. Where applicable, it can also support analysis of the association between HCP message resonance and intent-to-prescribe. For a therapy area such as Women’s Health and menopause, where individual experiences and information needs vary significantly, understanding these perspectives can be particularly valuable.
Because meaningful communication isn’t simply about reaching an audience. It’s about understanding what matters to them and what truly resonates.
Six Years On, the Conversation Continues
Looking back to 2020, it’s encouraging to see menopause receiving greater visibility and attention. Women have played a central role in driving that progress, sharing experiences, building supportive communities, and encouraging more open discussions about midlife health. As these conversations continue to evolve, they offer valuable opportunities to better understand the experiences and perspectives shaping healthcare discussions.
For Pharma and Agency partners, that understanding can provide a stronger foundation for communications that reflect real-life needs and resonate with the audiences they’re intended to reach. At Talking Medicines, we believe that better understanding enables more meaningful communication, with the potential to support better healthcare experiences and outcomes.
Six years on, it’s not simply about how much more is being said. It’s what we can learn from those conversations, and how that understanding shapes what we say next.